Bavunalimab
Bavunalimab (Anti-Human CTLA4xLAG3) is a bispecific human anti-CTLA-4/LAG-3 monoclonal antibody. Bavunalimab activates T cells in NSG mice. Bavunalimab can be used for the research of cancer[1].
Product Specifications
CAS Number
2329669-78-3
Product Name Alternative
Anti-Human CTLA4xLAG3; XmAb-22841
UNSPSC
12352203
Target
LAG-3
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/bavunalimab.html
Purity
99.408
Solubility
H2O
Smiles
[Bavunalimab]
Molecular Weight
(125.327 kDa)
References & Citations
[1]Perez-Santos M, et, al. Approaches for development of LAG-3 inhibitors and the promise they hold as anticancer agents. Expert Opin Drug Discov. 2022 Nov 24;1-15.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LY433313 100 µg
FAM130A2 (CSRNP3) (NM_001172173) Human Over-expression Lysate
Sign In for Pricing
View Details 